Cardiac magnetic resonance characterization of COVID-19 myocarditis
Meylin Caballeros Lam 1 , Ana de la Fuente Villena 2 , Aitor Hernández Hernández 2 , Manuel García de Yébenes 2 , Gorka Bastarrika Alemañ 3
(1) Departamento de Radiología, Clínica Universidad de Navarra, Madrid, Spain.
(2) Departamento de Cardiología, Clínica Universidad de Navarra, Madrid, Spain.
(3) Departamento de Radiología, Clínica Universidad de Navarra, Pamplona, Spain.
To the Editor,
Since its first description in December 2019 in Wuhan City (Hubei, China), a novel type of mutated coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has infected over 3.6 million people and caused more than 257 000 deaths worldwide (as of May 5, 2020).
There is growing concern that acute respiratory disease occurring in coronavirus disease (COVID-19) is strongly associated with cardiovascular damage. Patients with COVID-19 are at risk of cardiac arrhythmias, acute coronary syndromes, heart failure-related events, and fulminant myocarditis.1
Myocardial injury may occur at different phases of COVID-19 disease (ie, viral, pulmonary, inflammatory, and recovery phase), even late after the onset of symptoms.2 ...
CITA DEL ARTÍCULO Rev Esp Cardiol (Engl Ed). 2020 Jul 4;S1885-5857(20)30287-5. doi: 10.1016/j.rec.2020.06.018.